Shanghai, China, 15 June 2025 — MicroPort® MedBot™ recently announced that cumulative global orders for its robotic-assisted surgical system have exceeded 130 units, highlighting the accelerating adoption of its technologies across endoscopic, orthopedic, and vascular specialties.
At the forefront is the company’s flagship product Toumai® Surgical Robot, which has secured more than 70 commercial orders, with over 50 units already installed worldwide. To date, Toumai® has supported more than 10,000 procedures. The system has received regulatory clearance in over 30 countries and regions, reflecting its clinical reliability and global reach.
In January 2025, MicroPort® MedBot™ further expanded its orthopedic footprint with the SkyWalker® Orthopedic Surgical Robot, which obtained market approval from Health Canada — a significant step toward deepening its presence in major global markets.
The company also achieved a major milestone in telesurgery innovation. In April, Toumai® became the world’s first surgical robot to receive regulatory approval for full-spectrum remote surgical applications. Soon after, it enabled Europe’s first robot-assisted telesurgery, conducted by a Belgian surgeon via a hospital-grade V-LAN network with an ultra-low latency of just 20 milliseconds.
As it continues to expand its global presence, MicroPort® MedBot™ remains dedicated to redefining surgical precision, connectivity, and accessibility through its advanced robotic platforms.
About MicroPort® MedBot™
Commenced its development for laparoscopic surgery robots in 2014, and officially established in Shanghai in 2015, Shanghai MicroPort MedBot (Group) Co., Ltd. ("MicroPort® MedBot™", stock code: 02252.HK), a subsidiary of MicroPort Scientific Corporation ("MicroPort®", stock code: 00853.HK), is currently the only surgical robot company in the world with businesses covering five promising subsectors of surgical robots, including endoscopy, orthopedics, vascular intervention, natural orifice surgery, and percutaneous puncture. At MicroPort® MedBot™, we are committed to meeting the growing demand for cutting-edge robotic surgery. By integrating advanced research on robotics, control algorithms, image-based navigation, and precision imaging, we provide comprehensive intelligent surgical solutions to prolong and reshape the lives of patients, lead the advancement of robotic surgery, and shape the era of intelligent surgery.
More information is available at: www.medbotsurgical.com/en